Showing 41 - 60 results of 11,516 for search '(( 5 ht decrease ) OR ( 100 ((((nn decrease) OR (we decrease))) OR (a decrease)) ))', query time: 0.63s Refine Results
  1. 41
  2. 42
  3. 43
  4. 44
  5. 45
  6. 46
  7. 47
  8. 48
  9. 49
  10. 50
  11. 51
  12. 52

    Decreased S100A9 expression alleviates Clostridium perfringens beta2 toxin-induced inflammatory injury in IPEC-J2 cells by Jie Li (13877648)

    Published 2022
    “…<p><strong>Decreased </strong><em><strong>S100A9</strong></em><strong> expression alleviates </strong><em><strong>Clostridium perfringens</strong></em><strong> beta2 toxin-induced inflammatory injury in IPEC-J2 cells</strong></p>…”
  13. 53
  14. 54
  15. 55

    Pharmacological Mechanism of the Non-hallucinogenic 5‑HT<sub>2A</sub> Agonist Ariadne and Analogs by Michael J. Cunningham (14267038)

    Published 2022
    “…Compared to DOM, Ariadne shows lower signaling potency and efficacy in multiple signaling pathways examined (G<sub>q</sub>, G<sub>11</sub>, and β-arrestin2) coupled to 5-HT<sub>2A</sub> receptors. We confirmed the shift in signaling for an α-propyl analog and provide a molecular docking rationale for the progressive decrease in signaling potency with the growing length of the α-substituent. …”
  16. 56

    Pharmacological Mechanism of the Non-hallucinogenic 5‑HT<sub>2A</sub> Agonist Ariadne and Analogs by Michael J. Cunningham (14267038)

    Published 2022
    “…Compared to DOM, Ariadne shows lower signaling potency and efficacy in multiple signaling pathways examined (G<sub>q</sub>, G<sub>11</sub>, and β-arrestin2) coupled to 5-HT<sub>2A</sub> receptors. We confirmed the shift in signaling for an α-propyl analog and provide a molecular docking rationale for the progressive decrease in signaling potency with the growing length of the α-substituent. …”
  17. 57
  18. 58
  19. 59
  20. 60